High branched-chain α-keto acid intake, branched-chain α-keto acid dehydrogenase activity, and plasma and brain amino acid and plasma keto acid concentrations in rats

Pamela L. Crowell, Kevin P. Block, Joyce J. Repa, Nimbe Torres, M. Daud Nawabi, Maria G. Buse, Alfred E. Harper

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Diets containing high quantities of individual branched-chain α-keto acids (BCKAs) or a combination of BCKAs as used for treatment of renal disease were fed to rats. When the diet contained a single BCKA, its concentration was high in plasma and the concentration of its corresponding amino acid was high in plasma and brain. Liver BCKA dehydrogenase (BCKD) was 42% active in control rats. Consumption of diets containing 0.38 mol/kg diet of α-ketoisocaproate (KIC), α-keto-β-methylvalerate (KMV), or α-ketoisovalerate (KIV) resulted in complete activation of liver BCKD. Consumption of the diet containing the combination of BCKAs increased basal BCKD activity of liver twofold. Muscle BCKD was activated after feeding the KIV diet (2-fold), the KIC diet (3-fold), and the KMV diet (15-fold). Total BCKD activity of liver and muscle was unaffected by dietary treatments. Activation of liver and muscle BCKD by dietary BCKA is consistent with their ability to inhibit BCKD kinase in vitro.

Original languageEnglish (US)
Pages (from-to)313-319
Number of pages7
JournalAmerican Journal of Clinical Nutrition
Volume52
Issue number2
StatePublished - Aug 1990

Fingerprint

branched chain keto acids
3-methyl-2-oxobutanoate dehydrogenase (lipoamide)
3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)
Keto Acids
keto acids
Diet
brain
Amino Acids
amino acids
rats
Brain
diet
Oxidoreductases
liver
Liver
Muscles
muscles
kidney diseases
phosphotransferases (kinases)

Keywords

  • α-ketoisocaproate
  • Amino acid concentrations
  • Branched-chain α-keto acid dehydrogenase
  • Branched-chain α-keto acids
  • L-alloisoleucine

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

High branched-chain α-keto acid intake, branched-chain α-keto acid dehydrogenase activity, and plasma and brain amino acid and plasma keto acid concentrations in rats. / Crowell, Pamela L.; Block, Kevin P.; Repa, Joyce J.; Torres, Nimbe; Nawabi, M. Daud; Buse, Maria G.; Harper, Alfred E.

In: American Journal of Clinical Nutrition, Vol. 52, No. 2, 08.1990, p. 313-319.

Research output: Contribution to journalArticle

Crowell, Pamela L. ; Block, Kevin P. ; Repa, Joyce J. ; Torres, Nimbe ; Nawabi, M. Daud ; Buse, Maria G. ; Harper, Alfred E. / High branched-chain α-keto acid intake, branched-chain α-keto acid dehydrogenase activity, and plasma and brain amino acid and plasma keto acid concentrations in rats. In: American Journal of Clinical Nutrition. 1990 ; Vol. 52, No. 2. pp. 313-319.
@article{b6a977e7419241abb69f552c48a21365,
title = "High branched-chain α-keto acid intake, branched-chain α-keto acid dehydrogenase activity, and plasma and brain amino acid and plasma keto acid concentrations in rats",
abstract = "Diets containing high quantities of individual branched-chain α-keto acids (BCKAs) or a combination of BCKAs as used for treatment of renal disease were fed to rats. When the diet contained a single BCKA, its concentration was high in plasma and the concentration of its corresponding amino acid was high in plasma and brain. Liver BCKA dehydrogenase (BCKD) was 42{\%} active in control rats. Consumption of diets containing 0.38 mol/kg diet of α-ketoisocaproate (KIC), α-keto-β-methylvalerate (KMV), or α-ketoisovalerate (KIV) resulted in complete activation of liver BCKD. Consumption of the diet containing the combination of BCKAs increased basal BCKD activity of liver twofold. Muscle BCKD was activated after feeding the KIV diet (2-fold), the KIC diet (3-fold), and the KMV diet (15-fold). Total BCKD activity of liver and muscle was unaffected by dietary treatments. Activation of liver and muscle BCKD by dietary BCKA is consistent with their ability to inhibit BCKD kinase in vitro.",
keywords = "α-ketoisocaproate, Amino acid concentrations, Branched-chain α-keto acid dehydrogenase, Branched-chain α-keto acids, L-alloisoleucine",
author = "Crowell, {Pamela L.} and Block, {Kevin P.} and Repa, {Joyce J.} and Nimbe Torres and Nawabi, {M. Daud} and Buse, {Maria G.} and Harper, {Alfred E.}",
year = "1990",
month = "8",
language = "English (US)",
volume = "52",
pages = "313--319",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "2",

}

TY - JOUR

T1 - High branched-chain α-keto acid intake, branched-chain α-keto acid dehydrogenase activity, and plasma and brain amino acid and plasma keto acid concentrations in rats

AU - Crowell, Pamela L.

AU - Block, Kevin P.

AU - Repa, Joyce J.

AU - Torres, Nimbe

AU - Nawabi, M. Daud

AU - Buse, Maria G.

AU - Harper, Alfred E.

PY - 1990/8

Y1 - 1990/8

N2 - Diets containing high quantities of individual branched-chain α-keto acids (BCKAs) or a combination of BCKAs as used for treatment of renal disease were fed to rats. When the diet contained a single BCKA, its concentration was high in plasma and the concentration of its corresponding amino acid was high in plasma and brain. Liver BCKA dehydrogenase (BCKD) was 42% active in control rats. Consumption of diets containing 0.38 mol/kg diet of α-ketoisocaproate (KIC), α-keto-β-methylvalerate (KMV), or α-ketoisovalerate (KIV) resulted in complete activation of liver BCKD. Consumption of the diet containing the combination of BCKAs increased basal BCKD activity of liver twofold. Muscle BCKD was activated after feeding the KIV diet (2-fold), the KIC diet (3-fold), and the KMV diet (15-fold). Total BCKD activity of liver and muscle was unaffected by dietary treatments. Activation of liver and muscle BCKD by dietary BCKA is consistent with their ability to inhibit BCKD kinase in vitro.

AB - Diets containing high quantities of individual branched-chain α-keto acids (BCKAs) or a combination of BCKAs as used for treatment of renal disease were fed to rats. When the diet contained a single BCKA, its concentration was high in plasma and the concentration of its corresponding amino acid was high in plasma and brain. Liver BCKA dehydrogenase (BCKD) was 42% active in control rats. Consumption of diets containing 0.38 mol/kg diet of α-ketoisocaproate (KIC), α-keto-β-methylvalerate (KMV), or α-ketoisovalerate (KIV) resulted in complete activation of liver BCKD. Consumption of the diet containing the combination of BCKAs increased basal BCKD activity of liver twofold. Muscle BCKD was activated after feeding the KIV diet (2-fold), the KIC diet (3-fold), and the KMV diet (15-fold). Total BCKD activity of liver and muscle was unaffected by dietary treatments. Activation of liver and muscle BCKD by dietary BCKA is consistent with their ability to inhibit BCKD kinase in vitro.

KW - α-ketoisocaproate

KW - Amino acid concentrations

KW - Branched-chain α-keto acid dehydrogenase

KW - Branched-chain α-keto acids

KW - L-alloisoleucine

UR - http://www.scopus.com/inward/record.url?scp=0025351417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025351417&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 313

EP - 319

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 2

ER -